Advent France Biotechnology launches second fund

Samantha Birchall 30 September 2021

Advent France Biotechnology (AFB) has launched its second fund dedicated to early stage life sciences, with a first close at €86m.

Next article »

« Previous article

Related Articles

Innova closes seventh fund above hard-cap on €407m

07/05/24

CapMan Growth’s third fund hits €130m hard-cap

03/05/24

Bridgepoint invests in French risk manager Forward Global

02/05/24

Locate Bio attracts £9.2m in latest fundraise for LDGraft Clinical Study

01/05/24

Former Monzo leader launches angel fintech fund

01/05/24

IK Partners raises maiden continuation fund

26/04/24

Search